This pharmacological guideline for pandemic H1N1 Influenza includes recommendations on the use of some other potensial pharmacological treatments in addition of both neuroaminidase inhibitors and M2 inhibitors. Also, it covers guidance on the use of the antivirals for other seasonal influenza strains and for infections due to novel influenza A virus strains and a table of recommended dosages of therapy.
Tags: pandemic H1N1, pharmacological therapy, therapy guideline | Category: Swine Flu | Posted at November 6, 2009 with 0 Comments
